OakChart

FMC Corp

FMCBasic Materials·Agricultural Inputs·USA·Small·NYSE·Nov 11 • 8:51 AM ET

5.68+0.04 (0.71%)
2026-11-11 15:14 CET
Market cap
877.35 USD m
Revenue, TTM
2,814.90 USD m
Net income, TTM
-4,259.90 USD m
Free cash flow, TTM
295.60 USD m
EPS diluted, TTM
-33.05
P/E
-
Compare

Price

FMC against its 20, 50 and 200-day averages
2050200miss
5.0010.0015.0020.0016.3M32.6MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26FMCclose 5.6820-day 5.4650-day 8.27200-day 12.065.68

74.2% under 22.00 on 30 Oct 2025. Last 15 sessions, 51.9% high to low

Profile

FMC
52-week range, 9% of the way up
4.3718.29

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

IndexRUT
Employees5500
IPOSep 10, 1948
Beta0.53
ATR, 14d0.56
Rel volume0.01
Short float31.20%
Insider own20.89%
Inst own83.20%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap883.57M
Enterprise Value4.47B
Income-4.26B
Sales2.81B
Book/sh-0.12
Cash/sh4.73
Dividend Est.0.32 (5.62%)
Dividend TTM0.32 (5.63%)
Dividend Ex-DateSep 30, 2026
Dividend Gr. 3/5Y-5.69% 0.22%
Payout-
Employees5500
IPOSep 10, 1948

Ratios

P/E-
Forward P/E6.11
PEG-
P/S0.31
P/B-
P/C1.20
P/FCF2.99
EV/EBITDA-
EV/Sales1.59
Quick Ratio1.18
Current Ratio1.66
Debt/Eq-
LT Debt/Eq-
Option/ShortYes / Yes

Earnings

EPS (ttm)-33.05
EPS next Y0.93
EPS next Q0.58
EPS this Y-209.43%
EPS next Y128.71%
EPS next 5Y-22.68%
EPS past 3/5Y- -
Sales past 3/5Y-15.77% -5.67%
EPS Y/Y TTM-677.23%
Sales Y/Y TTM-21.99%
EPS Q/Q-243.32%
Sales Q/Q-80.47%
EarningsOct 29 AMC
EPS/Sales Surpr.-6874.19% -78.28%

Ownership

Insider Own20.89%
Insider Trans-0.02%
Inst Own83.20%
Inst Trans3.72%
ROA-41.79%
ROE-222.52%
ROIC-105.83%
Gross Margin19.44%
Oper. Margin-20.90%
Profit Margin-151.33%
SMA204.00%
SMA50-31.34%
SMA200-52.90%
Trades-

Technical

Shs Outstand155.56M
Shs Float123.07M
Short Float31.20%
Short Ratio6.84
Short Interest38.40M
52W High18.29 -68.94%
52W Low4.37 29.98%
Volatility8.93% 9.47%
ATR (14)0.56
RSI (14)41.03
Beta0.53
Rel Volume0.01
Avg Volume5.61M
Volume2,246

Performance

Perf Week-11.53%
Perf Month-31.65%
Perf Quarter-44.09%
Perf Half Y-55.38%
Perf YTD-59.05%
Perf Year-59.17%
Perf 3Y-88.91%
Perf 5Y-94.63%
Perf 10Y-87.49%
Recom2.95
Target Price7.18
Prev Close5.64
Price5.68
Change %0.71%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 16, 2026DowngradeJJefferiesBuy → Hold$5-12.0%
Sep 11, 2026ResumedKKeyBanc Capital MarketsOverweight$16+181.7%
Apr 22, 2026DowngradeVVertical ResearchHold → Sell$14+146.5%
Dec 09, 2025DowngradeBBarclaysEqual Weight → Underweight$13+128.9%
Nov 11, 2025ResumedWWells FargoEqual Weight$16+181.7%
Oct 31, 2025DowngradeWWells FargoOverweight → Equal Weight$16+181.7%
Oct 31, 2025DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight
Oct 30, 2025DowngradeBBarclaysOverweight → Equal Weight$22+287.3%
Oct 14, 2025UpgradeBBofA SecuritiesUnderperform → Neutral$33+481.0%
Jun 23, 2025UpgradeWWells FargoEqual Weight → Overweight$50+780.3%

Peers

Mkt cap
TickerCompanyMkt cap
CTVACorteva Inc8.14B
AVDAmerican Vanguard Corp24.23M
NTRNutrien Ltd34.52B
SMGScotts Miracle-Gro Company3.78B
ICLICL Group Ltd6.01B
BIOXBioceres Crop Solutions Corp13.69M
VYLRVylor Inc49.38B
MOSMosaic Company7.28B
IPIIntrepid Potash Inc446.37M
CFCF Industries Holdings Inc17.97B

Insider trading

6 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Scanlan JacquelineExecutive VP & Chief HRONov 03 '26Sale6.554,93032,29258,628Nov 05 04:08 PM
Scanlan JacquelineOfficerNov 03 '26Proposed Sale6.554,93032,292Nov 03 10:36 AM
Pfeiffer NicholasCorporate ControllerSep 09 '26Sale12.781,25115,98228,513Sep 10 04:11 PM
Pfeiffer NicholasOfficerSep 09 '26Proposed Sale12.781,25115,982Sep 09 11:10 AM
BARRY MICHAEL FDirectorMar 04 '26Buy13.8318,072249,93819,634Mar 05 12:11 PM
Raines John MitchellDirectorNov 13 '25Buy13.777,00096,39013,784Nov 14 09:19 AM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
VXFVanguard Extended Market Index ETFAUM: 30.47B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B

News

latest 14 of 206
  • FMC's $672 Million Channel Reset Buries The Quarter, And The Underlying Miss, Second Q4 Cut And Thin Covenant Headroom Matter More (Earnings Whispers) +30.53%
  • FMC: Q3 Earnings Snapshot (Associated Press) +6.26%
  • FMC Corporation Reports Third-Quarter 2026 Results and Revised Fourth-Quarter Outlook (PR Newswire)
  • FMC's Third-Quarter Sales Guidance Collapse Puts Full-Year Plan And Balance Sheet On Trial (Earnings Whispers) -5.27%
  • FMC Stock Dropped 31%-Why It May Still Be No Bargain (Barrons.com)
  • Loading…
  • Workday downgraded, Fox Corp. upgraded: Wall Street's top analyst calls (The Fly)
  • FMC Stock Crashes 33% On Massive Earnings Downgrade Citi expects Modest Negative Reaction For Peer Corteva (Stocktwits) -30.53%
  • FMC Shares Plunge 35% as Company Cuts Q3 2026 Outlook Amid Weak Demand and Inventory Pressures (InvestorsHub)
  • FMC tumbles 35% after slashing Q3 outlook over weak demand and inventory issues (Investing.com)
  • FMC Stock Plummets 38% on Horrendous Guidance (Barrons.com)
  • FMC Corporation Provides Update to Third-Quarter Expectations and Announces Comprehensive Commercial Actions to Expedite Return to Growth (PR Newswire)
  • FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil (PR Newswire)
  • FMC Corporation and Tessenderlo Group Complete Minority Equity Investment (PR Newswire) -6.34%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-29-4.4100.065-15.540105.9487.638
2026Q22026-07-290.2600.220-1.489867.1895.1414
2026Q12026-04-29-0.230-0.382-2.245762.4745.4216
2025Q42026-02-041.2001.196-13.7781,0831,15118
2025Q32025-10-290.8900.852-4.525961.31,06217
2025Q22025-07-300.6900.6180.5301,051996.7218
2025Q12025-04-300.1800.094-0.124791.4777.4618
2024Q42025-02-041.7901.602-0.1341,2241,31617
2024Q32024-10-290.6900.5690.5171,0651,04117
2024Q22024-07-310.6300.5532.3471,0381,03417
2024Q12024-05-060.3600.323-0.0229181,00916
2023Q42024-02-051.0701.0828.7501,1461,24017
2023Q32023-10-300.4400.539-0.028981.91,01016
2023Q22023-08-020.5000.6100.2421,0151,01716
2023Q12023-05-011.7701.7491.5511,3441,41717
2022Q42023-02-072.3702.3332.1621,6221,53018

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY6.0905.8683.6024,6104,602
2020FY6.1906.2134.2134,6424,641
2021FY6.9306.7845.7135,0455,001
2022FY7.4107.3845.7995,8025,709
2023FY3.7803.79210.5064,4874,582
2024FY3.4803.3122.7114,2464,337
2025FY2.9602.951-17.8803,8893,930
2026FY--3.239--2,843
2027FY-0.930--3,434
2028FY-1.368--3,598
2029FY-1.720--3,381
2030FY-1.770--3,010

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0712661,0499291,094
2026Q4S2026-11-0613661,0549291,112
2026Q4S2026-11-0213651,0619291,129
2026Q4S2026-10-3013551,0659291,129
2026Q4S2026-10-2913091,0338721,129
2026Q4S2026-10-1913091,0338721,129
2026Q4S2026-10-1613081,0418721,129
2026Q4S2026-10-1513071,0488721,129
2026Q4S2026-10-1413061,061900.121,129
2026Q4S2026-10-1313111,1141,0521,202
2026Q4S2026-10-0513721,1141,0521,202
2026Q4S2026-10-0213721,1141,0521,202
2026Q4S2026-09-2913721,1141,0521,202
2026Q4S2026-09-2813711,1161,0521,202

Estimate history

EPS, annual-1.0993.6333.6024.2135.7135.79910.5062.711-17.897-33.0472
Period201720182019202020212022202320242025TTM
EPS, quarterly0.517-0.134-0.1240.53-4.525-13.778-2.245-1.489-15.535
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2878.64285.34609.84642.15045.25802.34486.84246.13467.42814.9
Period201720182019202020212022202320242025TTM
Sales, quarterly1065.41224.3791.41050.5542.21083.3758.6867.1105.9
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual134.331132.282129.124129.354125.699125.111124.761124.841124.934155.558
Period201720182019202020212022202320242025MRQ
Shares, quarterly124.836124.841124.909124.912124.92124.934125.045125.227155.558
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,814.903,467.404,246.104,486.805,802.305,045.204,642.104,609.804,285.30
Cost of Goods Sold Incl. D&A2,267.602,290.802,668.802,578.503,415.502,858.602,576.702,618.202,365.60
Gross Profit547.301,176.601,577.301,908.302,386.802,186.602,065.401,991.601,919.70
Selling, General and Administrative Excl. Other1,135.60951.00922.601,070.401,095.901,020.10945.001,015.10982.80
Research and Development251.30266.10278.00328.80314.20304.70287.90298.10287.70
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-588.30225.60654.70837.901,290.901,166.501,120.40976.50936.90
Interest Expense272.20237.70233.90234.80147.80126.90148.60159.70134.10
Unusual Expense2,270.601,884.40325.60103.9095.60129.00223.50166.70294.10
Net Income Before Taxes-3,015.70-1,886.60252.50300.20983.90897.80729.80655.00608.40
Income Taxes1,155.30314.20-150.90-1,119.30145.2092.50150.90111.5070.80
Consolidated Net Income-4,175.30-2,201.90402.201,416.80837.00803.50577.50542.00535.20
Net Income From Continuing Operations-4,177.10-2,203.40401.701,417.30832.00806.00578.40539.20525.80
Net Income-4,259.90-2,240.00339.901,318.80734.80737.80550.10475.40493.70
EPS (Recurring)-20.07-7.364.5311.086.336.415.414.495.15
EPS (Basic, Before Extraordinaries)-33.05-17.902.7210.555.835.754.243.643.67
EPS (Diluted)-33.05-17.902.7110.515.805.714.213.603.63
EBITDA-324.50498.60905.701,089.101,457.301,327.101,278.701,217.501,094.70
Non-Operating Income (Expense)115.409.90157.30-199.00-63.60-12.80-18.504.9099.70
Other After Tax Adjustments-4.30-1.10-1.20-2.70-1.70-1.80-1.40-1.50-2.40
Stock Option Compensation Expense19.2819.0025.8316.2015.0911.1414.9020.2017.70
Price To Earnings Ratio--4.1916.0624.2319.3227.2827.2717.69
Price To Sales Ratio0.420.501.441.762.732.813.232.862.35
Gross Margin19.4433.9337.1542.5341.1443.3444.4943.2044.80
Operating Margin-20.906.5115.4218.6722.2523.1224.1421.1821.86
Net Margin-151.33-64.608.0029.3912.6614.6211.8510.3111.52
Shares Outstanding155.56124.93124.84124.76125.11125.70129.35129.12132.28
Market Capitalization877.35877.356,068.287,866.0615,720.5613,928.6714,912.9712,938.178,630.66

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue105.90867.10758.601,083.30542.201,050.50791.401,224.30
Cost of Goods Sold Incl. D&A530.10502.50500.60734.40438.80643.20474.40713.40
Gross Profit-424.20364.60258.00348.90103.40407.30317.00510.90
Selling, General and Administrative Excl. Other230.00418.60250.60236.40230.70243.20240.70228.80
Research and Development57.7060.4065.5067.7063.3066.4068.7072.20
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-654.20-54.007.40112.50-127.30164.1076.30282.10
Interest Expense73.1070.8064.3064.0063.6060.5049.6051.40
Unusual Expense453.40178.4091.401,547.40297.3032.8014.4058.80
Net Income Before Taxes-1,187.90-194.30-149.20-1,484.30-466.0058.804.90177.50
Income Taxes840.60-1.50112.10204.1082.2014.4013.50148.00
Consolidated Net Income-2,028.50-192.90-261.30-1,692.60-545.4044.20-8.6029.00
Net Income From Continuing Operations-2,030.10-193.20-261.40-1,692.40-546.1043.10-8.5028.80
Net Income-2,066.90-186.70-281.30-1,725.00-566.5066.50-15.50-16.80
EPS (Recurring)-13.15-0.49-1.73-5.13-2.860.71-0.040.19
EPS (Basic, Before Extraordinaries)-15.54-1.49-2.25-13.78-4.520.53-0.12-0.13
EPS (Diluted)-15.54-1.49-2.25-13.78-4.520.53-0.12-0.13
EBITDA-609.50-7.5053.30239.20-79.00214.90123.50386.10
Non-Operating Income (Expense)-7.20108.90-0.9014.6022.20-12.00-7.405.60
Other After Tax Adjustments0.00-0.100.00-4.202.80-0.200.00-0.50
Stock Option Compensation Expense5.776.082.375.065.215.45-4.74
Price To Earnings Ratio----42.6916.0315.584.19
Price To Sales Ratio0.420.440.630.501.171.271.281.43
Gross Margin-400.5742.0534.0132.2119.0738.7740.0641.73
Operating Margin-617.75-6.230.9810.38-23.4815.629.6423.04
Net Margin-1,951.75-21.53-37.08-159.24-104.486.33-1.96-1.37
Shares Outstanding155.56125.23125.05124.93124.92124.91124.91124.84
Market Capitalization877.351,438.022,153.271,732.644,200.795,214.955,269.706,068.28

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments584.50357.30302.40572.00516.80568.90339.10134.40283.00
Short Term Receivables2,362.203,165.502,945.103,043.802,809.902,528.002,460.402,359.002,174.00
Inventories1,219.601,201.601,724.601,651.601,521.901,095.601,017.001,025.50992.50
Other Current Assets792.70233.90157.00171.20205.20183.10258.30511.30203.20
Total Current Assets4,959.004,958.305,129.105,438.605,053.804,375.604,074.804,030.203,652.70
Net Property, Plant & Equipment812.30960.101,014.30973.40952.20919.00922.70756.901,025.20
Total Investments and Advances20.40145.7066.9056.3030.3027.200.700.7031.50
Long-Term Note Receivable79.9042.5022.9064.0059.70107.10138.10108.80176.50
Intangible Assets2,456.603,979.804,182.004,230.404,129.004,252.104,213.504,233.303,857.30
Deferred Tax Assets1,215.601,523.801,336.60210.70194.10229.60257.40272.80252.70
Other Assets143.4043.10174.40197.90254.00275.80265.50571.60210.40
Total Assets9,687.2011,653.3011,926.2011,171.3010,673.1010,186.409,872.709,974.309,206.30
Short Term Debt Incl. Current Port. of LT Debt1,331.40361.90958.40562.80464.30363.90259.20547.70192.60
Accounts Payable771.00768.50602.401,252.201,135.00946.70900.10795.50714.20
Income Tax Payable24.00122.50124.40114.7065.4082.2062.2085.1099.20
Other Current Liabilities1,628.901,766.301,699.401,869.901,855.601,436.201,502.401,565.101,203.40
Total Current Liabilities3,755.303,019.203,384.603,799.603,520.302,829.002,723.902,993.402,209.40
Long Term Debt2,867.403,134.003,146.802,861.802,871.703,080.603,194.302,162.303,015.50
Provision for Risks Charges739.20697.90588.20535.50528.00600.10597.10599.00507.60
Deferred Tax Liabilities54.1086.00158.10321.50342.40350.00333.20330.80173.20
Other Liabilities172.30207.40215.10252.00267.00342.50462.80678.40593.50
Total Liabilities7,588.307,144.507,492.807,770.407,529.407,202.207,311.306,763.906,499.20
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity2,071.504,487.504,410.903,377.903,124.302,961.802,532.303,121.102,681.80
Total Shareholders Equity2,071.504,487.504,410.903,377.903,124.302,961.802,532.303,121.102,681.80
Accumulated Minority Interest27.4021.3022.5023.0019.4022.4029.1089.3025.30
Total Equity2,098.904,508.804,433.403,400.903,143.702,984.202,561.403,210.402,707.10
Total Liabilities & Stockholders Equity9,687.2011,653.3011,926.2011,171.3010,673.1010,186.409,872.709,974.309,206.30
Book Value Per Share16.5835.9535.3527.0024.8622.9019.6123.5919.96
Tangible Book Value Per Share-3.084.071.83-6.81-7.99-9.97-13.02-8.41-8.75
Full-Time Employees5,5005,7006,6006,6006,4006,4006,4007,3007,000
Price to Book Ratio-45.221.322.394.934.555.025.092.725.19
Return on Assets-20.653.4112.277.657.735.775.435.48-1.12
Return on Equity-67.199.0336.3925.9626.4921.0619.0818.12-3.70
Return on Invested Capital-45.354.4617.4511.7812.309.108.309.34-2.59
Quick Ratio1.001.241.011.001.001.161.121.001.20
Current Ratio1.321.641.521.431.441.551.501.351.65

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-4,167.00-2,200.80403.401,419.50838.70805.30578.90543.50537.60
Depreciation167.10173.60176.30184.30169.40170.90162.70150.10150.20
Other Funds (Non Cash)3,134.202,244.40198.00173.0052.2057.8087.90142.1092.30
Funds from Operations119.30522.00437.40484.001,007.601,044.60863.10881.80736.20
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital232.00-602.20233.70-870.40-425.20-224.50-215.30-393.30-370.90
Income Taxes Payable59.20-186.40-5.40-62.8019.10-90.3036.20-25.00-94.70
Cash from Operating Activities351.30-80.20671.10-386.40582.40820.10647.80488.50365.30
Capital Expenditures-55.70-96.30-67.90-133.90-142.30-100.10-67.20-93.90-83.00
Net Assets From Acquisitions-2.50-23.20-4.80-16.50-198.20-5.20-73.000.000.00
Sale of Fixed Assets and Businesses0.000.00340.005.8050.500.000.000.00107.60
Purchase or Sale of Investments0.000.000.000.000.00-12.70-47.20-48.00-48.50
Purchase of Investments0.000.000.000.000.00-12.70-47.20-48.00-48.50
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses1.200.00-3.70-9.800.00-13.70-20.40-54.00-107.00
Other Sources23.5011.200.000.0023.6019.7031.109.200.00
Cash from Investing Activities-33.50-108.30263.60-154.40-266.40-112.00-176.70-186.70-130.90
Cash Dividends Paid-103.30-291.30-290.60-290.50-267.50-247.20-228.50-210.30-89.20
Change in Capital Stock393.80-1.60-2.10-75.90-99.50-400.10-33.70-365.50167.50
Repurchase of Common Pref Stock-1.40-1.80-2.30-81.20-108.90-408.00-58.40-416.20-206.80
Sale of Common Pref Stock395.200.200.205.309.407.9024.7050.70374.30
Proceedsfrom Stock Options395.200.200.205.309.407.9024.7050.70374.30
Issuance or Reduction of Debt, Net-375.80692.50-576.70699.30113.80-100.6020.60488.80-472.50
Change in Long Term Debt678.60233.000.00298.60-1.40-205.50-76.40500.70-552.00
Issuance of Long Term Debt1,179.10733.600.001,498.600.00997.6023.601,402.600.00
Reduction of Long Term Debt-500.50-500.600.00-1,200.00-1.40-1,203.10-100.00-901.90-552.00
Net Financing Active Other Cash Flow-3.00-5.00-0.70-1.4015.800.00-1.30-37.2034.00
Other Financing Activities Uses-3.00-5.00-0.70-1.40-0.500.00-1.30-37.200.00
Cash from Financing Activities-88.30394.60-870.10331.50-237.40-747.90-242.90-124.20-360.20
Exchange Rate Effect8.6021.10-9.70-60.30-23.40-12.301.60-0.204.50
Net Change in Cash238.10227.2054.90-269.6055.20-52.10229.80177.40-121.30
Free Cash Flow295.60-176.50603.20-520.30440.10720.00580.60394.60282.30
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow6.17-19.49-91.6230.0242.6271.4952.04
Deferred Taxes & Investment Tax Credit-304.80-340.30-1,292.80-52.7010.6033.6046.10-43.90

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments735.80476.60390.90584.50497.70438.20
Short Term Receivables1,723.102,070.502,244.802,362.202,330.103,076.30
Inventories1,326.501,209.301,242.601,219.601,375.901,395.70
Other Current Assets792.00972.301,026.60792.701,363.60557.10
Total Current Assets4,577.404,728.704,904.904,959.005,567.305,467.30
Net Property, Plant & Equipment592.70658.20731.20812.30951.20992.20
Total Investments and Advances213.20113.50167.3020.40332.30117.20
Intangible Assets1,995.902,307.902,333.502,456.603,739.103,928.40
Deferred Tax Assets435.001,134.301,096.001,215.601,456.701,549.50
Other Assets67.50151.30103.20143.40-47.20181.30
Total Assets7,909.809,144.809,419.509,687.2012,078.8012,297.10
Short Term Debt Incl. Current Port. of LT Debt251.50354.101,789.601,331.401,296.00917.90
Accounts Payable723.90657.80634.10771.00733.60906.00
Income Tax Payable105.0043.1026.6024.0077.9077.50
Other Current Liabilities1,678.101,324.401,363.001,628.901,883.101,671.70
Total Current Liabilities2,758.502,379.403,813.303,755.303,990.603,573.10
Long Term Debt4,044.804,048.602,867.002,867.403,365.503,368.80
Provision for Risks Charges582.50579.50596.80739.20536.10646.30
Deferred Tax Liabilities44.1050.4049.0054.1092.4094.10
Other Liabilities470.40425.80243.50172.30293.40186.70
Total Liabilities7,900.307,483.707,569.607,588.308,278.007,869.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-19.401,636.801,822.102,071.503,773.804,397.00
Total Shareholders Equity-19.401,636.801,822.102,071.503,773.804,397.00
Accumulated Minority Interest28.9024.3027.8027.4027.0031.10
Total Equity9.501,661.101,849.902,098.903,800.804,428.10
Total Liabilities & Stockholders Equity7,909.809,144.809,419.509,687.2012,078.8012,297.10
Book Value Per Share-0.1213.0714.5716.5830.2135.20
Tangible Book Value Per Share-12.96-5.36-4.09-3.080.283.75
Full-Time Employees---5,500--
Price to Book Ratio-45.220.791.040.460.961.19
Return on Assets-41.79-25.12-23.16-20.65-3.971.06
Return on Equity-222.52-89.27-79.20-67.20-11.522.88
Return on Invested Capital-51.35-3.28-6.00-34.93-7.930.86
Quick Ratio1.181.480.961.001.051.14
Current Ratio1.661.991.291.321.401.53

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-2,028.50-192.80-261.30-1,684.40-552.2044.40
Depreciation40.9041.1042.0043.1043.4043.40
Other Funds (Non Cash)1,174.10207.80118.001,634.30566.9030.90
Funds from Operations-113.4012.2028.80191.70141.80122.70
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital100.10316.50-629.70445.10-350.00-73.20
Income Taxes Payable124.5015.30-29.60-51.00-13.20-74.20
Cash from Operating Activities-13.30328.70-600.90636.80-208.2049.50
Capital Expenditures-7.80-5.30-16.60-26.00-23.70-15.00
Net Assets From Acquisitions-0.10-0.30-0.40-1.70-8.70-4.60
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.001.20-0.605.20
Other Sources-0.3011.800.8011.200.000.00
Cash from Investing Activities-8.206.20-16.20-15.30-33.00-14.40
Cash Dividends Paid-10.20-10.20-10.00-72.90-72.90-72.80
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock395.10-0.30-0.90-0.10-0.300.00
Repurchase of Common Pref Stock-0.10-0.30-0.90-0.10-0.300.00
Sale of Common Pref Stock395.200.000.000.000.000.00
Proceedsfrom Stock Options395.200.000.000.000.000.00
Issuance or Reduction of Debt, Net-106.00-249.90453.20-473.10367.00163.70
Change in Long Term Debt-1.30682.200.00-2.30-14.60249.90
Issuance of Long Term Debt-1.301,182.200.00-1.80-14.60750.00
Reduction of Long Term Debt0.00-500.000.00-0.500.00-500.10
Net Financing Active Other Cash Flow0.00-3.000.000.009.60-13.30
Other Financing Activities Uses0.00-3.000.000.009.60-13.30
Cash from Financing Activities278.90-263.40442.30-546.10303.4077.60
Exchange Rate Effect1.80-1.50-3.1011.40-2.7010.20
Net Change in Cash259.2085.70-193.6086.8059.50122.90
Free Cash Flow-21.10323.40-617.50610.80-231.9034.50
Price to Free Cash Flow6.17-----

Revenue breakdown

Fungicides2024: 352.50M 2025: 362.80M
Herbicides2024: 1.28B 2025: 1.25B
Insecticides2024: 2.38B 2025: 1.57B
Plant Health2024: 200.50M 2025: 190.90M
Product and Service, Other2024: 34.70M 2025: 94.10M
Asia2024: 848.40M 2025: 142.30M
EMEA2024: 834.80M 2025: 871.50M
Latin America2024: 1.39B 2025: 1.35B
North America2024: 1.17B 2025: 1.10B
Total Chemicals & Allied Products revenue2024: 4.25B 2025: 3.47B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3031.20%38.4M123.1M5.27M
2026-10-1524.77%30.5M123.1M4.25M
2026-09-3025.20%29.0M115.2M3.72M
2026-09-1521.60%26.7M123.8M3.95M
2026-08-3123.87%29.6M123.8M3.93M
2026-08-1423.97%29.7M123.8M3.99M
2026-07-3121.58%26.7M123.8M3.97M
2026-07-1521.94%27.2M123.8M3.79M
2026-06-3021.06%26.0M123.6M3.44M
2026-06-1515.78%19.5M123.5M3.32M
2026-05-2913.94%17.2M123.6M3.31M
2026-05-1514.77%18.3M123.6M3.37M
2026-04-3010.39%12.8M123.6M4.01M
2026-04-1510.30%12.7M123.7M4.10M
2026-03-3112.35%15.3M124.0M4.37M
2026-03-1311.92%14.8M124.0M4.20M
2026-02-2712.67%15.7M123.9M4.40M
2026-02-1313.34%16.5M123.9M4.68M
2026-01-3012.73%15.8M123.9M4.91M
2026-01-1510.63%13.2M123.9M5.34M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.003.96-22.000.00---
call5.000.000.000.50-2,2960.00---
call7.500.000.000.08-2,1270.00---
call10.000.000.000.03-2,6520.00---
call12.500.000.000.05-3030.00---
call15.000.000.000.03-1340.00---
call17.500.000.000.15-3.000.00---
call20.000.000.000.00-0.000.00---
call22.500.000.000.03-3.000.00---
put2.500.000.000.04-22,0180.00---
put5.000.000.000.14-1,2990.00---
put7.500.000.001.95-1,1610.00---
put10.000.000.004.70-68.000.00---
put12.500.000.004.20-0.000.00---
put15.000.000.005.73-0.000.00---
put17.500.000.006.89-0.000.00---
put20.000.000.000.00-0.000.00---
put22.500.000.000.00-0.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13GSEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-27SCHEDULE 13G/ASEC
2026-10-218-KCurrent report2026-10-15SEC
2026-10-218-KCurrent report2026-10-21SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-158-KCurrent report2026-10-15SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-25SCHEDULE 13DSEC
2026-09-253Initial statement of beneficial ownership of securities2026-09-23SEC
2026-09-238-KCurrent report2026-09-23SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-09144Filing for proposed sale of securities under Rule 144.SEC
2026-08-07SCHEDULE 13GSEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-28SCHEDULE 13G/ASEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-16SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110032.29K1
2026-100000
2026-090015.98K1
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-03249.94K100
2026-020000
2026-010000
2025-120000
2025-11232.35K200

Institutional holders

Manager% owned
BlackRock, Inc.17.22%
AQR CAPITAL MANAGEMENT LLC6.42%
VANGUARD PORTFOLIO MANAGEMENT LLC6.17%
STATE STREET CORP5.21%
VANGUARD CAPITAL MANAGEMENT LLC4.61%
AMERICAN CENTURY COMPANIES INC4.04%
D. E. Shaw & Co., Inc.3.93%
TWO SIGMA INVESTMENTS, LP2.26%
GEODE CAPITAL MANAGEMENT, LLC2.06%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.90%

Funds

Fund% owned
iShares iBonds 2026 Term High Yield and Income ETF26.09%
BlackRock Total Return Fund22.88%
PIMCO Income Fund21.59%
BlackRock High Yield Portfolio21.48%
LORD ABBETT BOND DEBENTURE FUND INC20.44%
VanEck Fallen Angel High Yield Bond ETF19.82%
iShares Broad USD High Yield Corporate Bond ETF11.77%
iShares Fallen Angels USD Bond ETF11.73%
T. Rowe Price High Yield Fund, Inc.10.86%
Income Fund of America10.42%

OakChart. FMC. Cached 15 minutes.